发明名称 |
Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias |
摘要 |
The present invention relates to a method of treating a warm-blooded animal, especially a human, having Mixed Lineage Leukemia (MLL rearranged ALL) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially PKC412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of MLL rearranged ALL; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of MLL rearranged ALL. |
申请公布号 |
US2014303146(A1) |
申请公布日期 |
2014.10.09 |
申请号 |
US201414311834 |
申请日期 |
2014.06.23 |
申请人 |
Griffin James Douglas;Fabbro Doriano |
发明人 |
Griffin James Douglas;Fabbro Doriano |
分类号 |
A61K31/553 |
主分类号 |
A61K31/553 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating mixed lineage leukemia gene rearranged acute lymphoblastic leukemia (MLL rearranged ALL) in a human patient in need thereof comprising administering a therapeutically effective amount in the range from 100 mg/day to 1000 mg/day of PKC412, or a pharmaceutically acceptable salt thereof, to the human having MLL rearranged ALL. |
地址 |
Brookline MA US |